77 related articles for article (PubMed ID: 1696829)
1. Isolation and characterization of human fibroblast tenascin. An extracellular matrix glycoprotein of interest for developmental studies.
Oike Y; Hiraiwa H; Kawakatsu H; Nishikai M; Okinaka T; Suzuki T; Okada A; Yatani R; Sakakura T
Int J Dev Biol; 1990 Jun; 34(2):309-17. PubMed ID: 1696829
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and structural studies of tenascin/hexabrachion proteins.
Taylor HC; Lightner VA; Beyer WF; McCaslin D; Briscoe G; Erickson HP
J Cell Biochem; 1989 Oct; 41(2):71-90. PubMed ID: 2482292
[TBL] [Abstract][Full Text] [Related]
3. Isolation of chick tenascin variants and fragments. A C-terminal heparin-binding fragment produced by cleavage of the extra domain from the largest subunit splicing variant.
Chiquet M; Vrucinić-Filipi N; Schenk S; Beck K; Chiquet-Ehrismann R
Eur J Biochem; 1991 Jul; 199(2):379-88. PubMed ID: 1712728
[TBL] [Abstract][Full Text] [Related]
4. [Identification of a protein with properties of tenascin in the matrix of embryonal cartilage tissue and in a culture of human embryonal fibroblasts].
Safronova EE
Biull Eksp Biol Med; 1990 Sep; 110(9):276-8. PubMed ID: 1702684
[TBL] [Abstract][Full Text] [Related]
5. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.
Howeedy AA; Virtanen I; Laitinen L; Gould NS; Koukoulis GK; Gould VE
Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508
[TBL] [Abstract][Full Text] [Related]
6. An alpha2-macroglobulin-serine proteinase complex from human carcinomatous ascites and pleural effusion: isolation, monoclonal antibody preparation, and immunohistochemical study.
Arima K; Nakamura Y; Takami N; Mizusaki K; Yoshida N; Okamoto K
Oncol Res; 1998; 10(10):499-507. PubMed ID: 10338153
[TBL] [Abstract][Full Text] [Related]
7. [Relationship of an extracellular matrix protein, tenascin and breast diseases].
Ishihara A; Yatani R; Sakakura T
Rinsho Byori; 1993 Oct; 41(10):1099-107. PubMed ID: 7504753
[TBL] [Abstract][Full Text] [Related]
8. Tenascin induction in tenascin nonproducing carcinoma cell lines in vivo and by TGF-beta 1 in vitro.
Sakai T; Kawakatsu H; Ohta M; Saito M
J Cell Physiol; 1994 Jun; 159(3):561-72. PubMed ID: 7514613
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.
Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Huang JY; Kristensen P; Danø K
Thromb Haemost; 1986 Apr; 55(2):206-12. PubMed ID: 3520936
[TBL] [Abstract][Full Text] [Related]
10. Influence of janusin and tenascin on growth cone behavior in vitro.
Taylor J; Pesheva P; Schachner M
J Neurosci Res; 1993 Jul; 35(4):347-62. PubMed ID: 7689656
[TBL] [Abstract][Full Text] [Related]
11. Characterization of tenascin secreted by human melanoma cells.
Herlyn M; Graeven U; Speicher D; Sela BA; Bennicelli JL; Kath R; Guerry D
Cancer Res; 1991 Sep; 51(18):4853-8. PubMed ID: 1716515
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a new human cell line, LI90, exhibiting characteristics of hepatic Ito (fat-storing) cells.
Murakami K; Abe T; Miyazawa M; Yamaguchi M; Masuda T; Matsuura T; Nagamori S; Takeuchi K; Abe K; Kyogoku M
Lab Invest; 1995 Jun; 72(6):731-9. PubMed ID: 7540235
[TBL] [Abstract][Full Text] [Related]
13. Recognition molecules myelin-associated glycoprotein and tenascin-C inhibit integrin-mediated adhesion of neural cells to collagen.
Bachmann M; Conscience JF; Probstmeier R; Carbonetto S; Schachner M
J Neurosci Res; 1995 Mar; 40(4):458-70. PubMed ID: 7542351
[TBL] [Abstract][Full Text] [Related]
14. Characterization and distribution in human tissues of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D.
Pancino G; Charpin C; Osinaga E; Betaille B; Le Roy M; Calvo F; Roseto A
Cancer Res; 1990 Nov; 50(22):7333-42. PubMed ID: 2224861
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of tenascin expression in mesenchyme by epithelial-mesenchymal interactions.
Ekblom P; Aufderheide E
Int J Dev Biol; 1989 Mar; 33(1):71-9. PubMed ID: 2484680
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Mr 40,000 polypeptide from colorectal cancer which expresses organ-specific cancer neoantigen activity as determined by leukocyte adherence inhibition.
Artigas C; Thomson DM; Durko M; Sutherland M; Scanzano R; Shenouda G; Dubois AE
Cancer Res; 1986 Apr; 46(4 Pt 1):1874-81. PubMed ID: 2418955
[TBL] [Abstract][Full Text] [Related]
17. Tenascin expression in normal and abnormal human endometrium.
Sasano H; Nagura H; Watanabe K; Ito K; Tsuiki A; Sato S; Yajima A; Kusakabe M; Sakakura T
Mod Pathol; 1993 May; 6(3):323-6. PubMed ID: 7688462
[TBL] [Abstract][Full Text] [Related]
18. A simple procedure for tenascin purification.
Saginati M; Siri A; Balza E; Ponassi M; Zardi L
Eur J Biochem; 1992 Apr; 205(2):545-9. PubMed ID: 1374029
[TBL] [Abstract][Full Text] [Related]
19. Can tenascin be redundant in cancer development?
Sakakura T; Kusakabe M
Perspect Dev Neurobiol; 1994; 2(1):111-16. PubMed ID: 7530137
[TBL] [Abstract][Full Text] [Related]
20. Regulation of astrocytic tenascin by basic fibroblast growth factor.
Meiners S; Marone M; Rittenhouse JL; Geller HM
Dev Biol; 1993 Dec; 160(2):480-93. PubMed ID: 7504635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
